Literature DB >> 24976733

Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices.

Xing-Rong Hu1, Xian-Nian Cui1, Qi-Tuo Hu1, Jun Chen1.   

Abstract

AIM: To compare apparent diffusion coefficient (ADC) values on diffusion-weighted imaging (DWI) of hepatic fibrosis patients with those of healthy controls and to identify their correlations with serum indices of liver fibrosis.
METHODS: Hyaluronic acid (HA), laminin (LN), type III procollagen (PCIII), and collagen type IV (IV-C) were measured in 54 hepatic fibrosis patients and 23 normal controls, and ADC values were determined on DWI at different b values (b = 300, 500, 700 s/mm(2)). Correlations between serum indices and ADC values at different liver fibrosis stages were examined, and each index variation of liver fibrosis in different stages were compared, and correlation analysis of each index and the staging of liver fibrosis carried out, and the correlation of each index performed.
RESULTS: With progressive liver fibrosis, HA, PCIII, and IV-C levels increased (P < 0.01). As the b value increased, the ADC value decreased gradually with the hepatic fibrosis stages. In different groups with b values of 500 s/mm(2) and 700 s/mm(2), the ADC value decreased significantly as liver fibrosis progressed (P < 0.01). With b values of 500 s/mm(2) and 700 s/mm(2), there were negative correlations between ADC and LN, PCIII, HA, and IV-C. This pattern was observed only for HA and IV-C at a b value of 300 s/mm(2).
CONCLUSION: Serum indices of liver fibrosis and ADC values are useful for diagnosing liver fibrosis, with some correlations among them.

Entities:  

Keywords:  Biological marker; Diffusion-weighted imaging; Hyaluronic acid; Laminin; Liver cirrhosis

Mesh:

Substances:

Year:  2014        PMID: 24976733      PMCID: PMC4069324          DOI: 10.3748/wjg.v20.i24.7964

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil.

Authors:  F Ståhlberg; S Brockstedt; C Thomsen; R Wirestam
Journal:  Acta Radiol       Date:  1999-05       Impact factor: 1.990

Review 2.  Basic principles of diffusion-weighted imaging.

Authors:  Roland Bammer
Journal:  Eur J Radiol       Date:  2003-03       Impact factor: 3.528

Review 3.  Cirrhosis and chronic liver failure: part II. Complications and treatment.

Authors:  Joel J Heidelbaugh; Maryann Sherbondy
Journal:  Am Fam Physician       Date:  2006-09-01       Impact factor: 3.292

Review 4.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

Review 5.  Hepatic stellate cells and liver fibrosis.

Authors:  Roger Klein Moreira
Journal:  Arch Pathol Lab Med       Date:  2007-11       Impact factor: 5.534

6.  Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.

Authors:  Kiminori Fujimoto; Tatsuyuki Tonan; Sanae Azuma; Masayoshi Kage; Osamu Nakashima; Takeshi Johkoh; Naofumi Hayabuchi; Koji Okuda; Takumi Kawaguchi; Michio Sata; Aliya Qayyum
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

Review 7.  Non-invasive assessment of chronic liver and gastric diseases.

Authors:  Mario Plebani; Daniela Basso
Journal:  Clin Chim Acta       Date:  2007-02-20       Impact factor: 3.786

8.  Reversal of liver cirrhosis in autoimmune hepatitis.

Authors:  Anish M Shah; Ashish Malhotra; Shivangi Kothari; Walid Baddoura; Joseph Depasquale; Robert Spira
Journal:  Hepatogastroenterology       Date:  2011 Nov-Dec

Review 9.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 10.  Diagnosis and quantitation of fibrosis.

Authors:  Diarmuid S Manning; Nezam H Afdhal
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

View more
  3 in total

1.  Lnc-TCL6 is a potential biomarker for early diagnosis and grade in liver-cirrhosis patients.

Authors:  Lei-Jia Li; Xiao-Ying Wu; Si-Wei Tan; Zi-Jun Xie; Xue-Mei Pan; Shun-Wen Pan; Wu-Ri-Na Bai; Hai-Jiao Li; Hui-Ling Liu; Jie Jiang; Bin Wu
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-10-11

2.  Quantitative T2 mapping of rats with chronic hepatitis.

Authors:  Xiaofeng Wang; Yan Hu; Xin Lu; Yu Cai; Jian Shu
Journal:  Exp Ther Med       Date:  2021-01-18       Impact factor: 2.447

3.  Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B.

Authors:  Tiffany P Hennedige; Gang Wang; Fiona P Leung; Hind S Alsaif; Lynette Ls Teo; Seng Gee Lim; Aileen Wee; Sudhakar K Venkatesh
Journal:  Gut Liver       Date:  2017-05-15       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.